Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MAT2A | P31153 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13384794 | 0.89 | KDM4E (0.47) | KDM4ENPSR1USP2HSD17B10L3MBTL1 | |
| SCHEMBL13384751 | 0.87 | USP2 (0.40) | KDM4ENPSR1USP2HSD17B10L3MBTL1 | |
| SCHEMBL13384796 | 0.87 | KDM4E (0.46) | KDM4ENPSR1USP2HSD17B10L3MBTL1 | |
| SCHEMBL13384770 | 0.85 | ALDH1A1 (0.42) | KDM4ENPSR1USP2HSD17B10L3MBTL1 | |
| SCHEMBL30608121 | 0.83 | ALDH1A1 (0.53) | KDM4ENPSR1ALDH1A1HPGDRXFP1 | |
| SCHEMBL26126788 | 0.83 | ALDH1A1 (0.53) | KDM4ENPSR1ALDH1A1HPGDRXFP1 | |
| SCHEMBL30608069 | 0.81 | MAPK8 (0.49) | KDM4ENPSR1L3MBTL1ALDH1A1HPGD | |
| SCHEMBL26125920 | 0.81 | MAPK8 (0.49) | KDM4ENPSR1L3MBTL1ALDH1A1HPGD | |
| SCHEMBL13384742 | 0.79 | MAT2A (0.40) | KDM4ENPSR1ALDH1A1HPGDRXFP1 | |
| SCHEMBL13384791 | 0.78 | KDM4E (0.41) | KDM4ENPSR1USP2HSD17B10L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087649-A1 | QUINOLINONE DERIVATIVES | TIBOTEC BVBA (BE) | 2010-04-08 | — | — | US | disclosed |
| US-20100087649-A1 | QUINOLINONE DERIVATIVES | TIBOTEC BVBA (BE) | 2010-04-08 | — | — | US | disclosed |
| WO-2008037784-A1 | QUINOLINONE DERIVATIVES | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2008-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087649-A1 | QUINOLINONE DERIVATIVES | CHRM1, CYP2C8, CCR8 | KDM4E 2122/4885NPSR1 524/4885USP2 3250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.